Cetuximab-IRDye800CW
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cetuximab-IRDye800CW, covering 2021-05-03 to 2021-05-03. Get the full timeline:
Most recent: Clinical Trial Update: Image Guided Surgery for Margin Assessment of Head and Neck Cancer Using Cetuximab-IRDye800CW cONjugate [Phase 1, Phase 2]